Vitamin Shoppe Target of Unusually High Options Trading (VSI)

Vitamin Shoppe Inc (NYSE:VSI) was the target of unusually large options trading on Monday. Stock traders purchased 5,804 call options on the stock. This is an increase of 6,810% compared to the average daily volume of 84 call options.

Several research analysts have recently issued reports on the company. ValuEngine raised Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Morgan Stanley reaffirmed an “equal weight” rating and set a $7.50 price objective (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Zacks Investment Research raised Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Wednesday, October 25th. Finally, Barclays lowered their price objective on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating for the company in a research report on Thursday, November 9th. Four investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. Vitamin Shoppe presently has a consensus rating of “Hold” and a consensus target price of $5.00.

Shares of Vitamin Shoppe (NYSE VSI) opened at $5.00 on Thursday. Vitamin Shoppe has a fifty-two week low of $2.95 and a fifty-two week high of $23.85. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32. The firm has a market capitalization of $119.89, a PE ratio of -0.47 and a beta of 0.68.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The firm had revenue of $288.20 million during the quarter, compared to analysts’ expectations of $297.61 million. During the same period in the previous year, the firm posted $0.50 earnings per share. The firm’s revenue for the quarter was down 8.5% on a year-over-year basis. analysts anticipate that Vitamin Shoppe will post 0.34 earnings per share for the current fiscal year.

In other Vitamin Shoppe news, major shareholder Vintage Capital Management Llc acquired 133,804 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was acquired at an average cost of $4.28 per share, with a total value of $572,681.12. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Over the last ninety days, insiders have bought 694,839 shares of company stock valued at $3,214,809. Insiders own 1.07% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. FMR LLC lifted its holdings in shares of Vitamin Shoppe by 32.4% in the 2nd quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the last quarter. Canada Pension Plan Investment Board lifted its holdings in shares of Vitamin Shoppe by 175.5% in the 3rd quarter. Canada Pension Plan Investment Board now owns 652,600 shares of the specialty retailer’s stock valued at $3,491,000 after purchasing an additional 415,700 shares during the last quarter. GMT Capital Corp purchased a new stake in shares of Vitamin Shoppe in the 3rd quarter valued at about $3,423,000. Schwab Charles Investment Management Inc. lifted its holdings in shares of Vitamin Shoppe by 23.5% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 323,786 shares of the specialty retailer’s stock valued at $1,733,000 after purchasing an additional 61,663 shares during the last quarter. Finally, Systematic Financial Management LP lifted its holdings in shares of Vitamin Shoppe by 94.9% in the 3rd quarter. Systematic Financial Management LP now owns 217,345 shares of the specialty retailer’s stock valued at $1,163,000 after purchasing an additional 105,855 shares during the last quarter. 90.35% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/11/vitamin-shoppe-target-of-unusually-high-options-trading-vsi.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply